Skip to main content

and
  1. Article

    Open Access

    Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

    The variable penetrance of breast cancer in BRCA1/2 mutation carriers suggests that other genetic or environmental factors modify breast cancer risk. Two genes of special interest are prohibitin (PHB) and methyle...

    A Jakubowska, D Rozkrut, A Antoniou, U Hamann, R J Scott in British Journal of Cancer (2012)

  2. Article

    Open Access

    The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

    The TP53 pathway, in which TP53 and its negative regulator MDM2 are the central elements, has an important role in carcinogenesis, particularly in BRCA1- and BRCA2-mediated carcinogenesis. A single nucleotide pol...

    O M Sinilnikova, A C Antoniou, J Simard, S Healey, M Léoné in British Journal of Cancer (2009)

  3. No Access

    Article

    Molekulares Staging und Vorhersage von Therapieansprechen beim Mammakarzinom

    Da der Großteil der Mammakarzinome Östrogenrezeptor-positiv ist und potenziell geringer auf eine Chemotherapie anspricht, ist die Identifizierung der Patientinnen, die von einer solchen Therapie profitieren, v...

    PD Dr. G. Sauer, N. Schneiderhan-Marra, C. Kurzeder, R. Kreienberg in Der Gynäkologe (2007)

  4. Article

    Open Access

    Ultrasound-guided large-core needle biopsies of breast lesions: analysis of 962 cases to determine the number of samples for reliable tumour classification

    The objective of this one-institutional study was to determine the number of large-core needle biopsies (LCNB), under three-dimensional ultrasound (3D-US) validation, that are sufficient to obtain a reliable h...

    G Sauer, H Deissler, K Strunz, G Helms, E Remmel, K Koretz in British Journal of Cancer (2005)